Optic Nerve Glioma - 10 Studies Found

Withdrawn : Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
: Optic Nerve Glioma
: 2010-12-13
:
  • Drug: Temozolomide Study subje
Active, not recruiting : PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
:
  • Neurofibromatosis-1
  • Optic Glioma
  • Pilomyxoid Astrocytoma
  • Pilocytic Astrocytoma
  • Glioma, Astro
    : 2013-04-16
    :
    • Drug: Mebendazole Mebendazole

Withdrawn : Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
:
  • Astrocytoma
  • Brainstem Glioma
  • Ependymoma
  • Radiation: Radiation therapy
  • Drug: Temozol
Recruiting : Phase II Pegylated Interferon
:
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas

: 2015-01-08
: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o
Not yet recruiting : Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Dermal Neurofibroma
:
  • Appearance Distress
  • Bothered by Itching Skin
  • Cafe Au Lait
    : 2016-07-20
    :
    • Other: Laboratory Biomarker Analysis

Active, not recruiting : Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
:
  • Neurofibromatosis Type 1
  • Recurrent Childhood Pilocytic Astrocytoma
  • Drug: Lenalidomide Given PO
Terminated : Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas
:
  • neurofibromatosis1 (NF1)
  • Recurrent or Progressive Optic Pathway Gliomas (OPG)
  • : 2011-04-18
    : Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will
Recruiting : Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
:
  • Glioma
  • Neurofibromatosis Type 1
  • Recurrent Childhood Pilocy
    : 2010-03-17
    :
    • Other: Laboratory Biomarker Analysis